Skip to main content
Caprolactam Chemicals ltd. logo

Caprolactam Chemicals ltd. — Investor Relations & Filings

Ticker · 507486 ISIN · INE470N01010 BSE.NS Manufacturing
Open in API
Filings indexed 335 across all filing types
Latest filing 2026-06-01 Report Publication Anno…
Country IN India
Listing BSE.NS 507486

About Caprolactam Chemicals ltd.

https://www.caprolactam.co.in

Caprolactam Chemicals Ltd. specializes in the manufacturing and processing of chemical products, with a primary focus on the production and recovery of Caprolactam. The company operates a chemical plant equipped for distillation and purification processes, catering to the requirements of the synthetic fiber and plastics sectors. Its core activities involve the conversion of raw materials and chemical intermediates into high-quality industrial chemicals. Caprolactam Chemicals Ltd. leverages technical expertise in chemical engineering to provide essential components for the manufacturing of Nylon 6, engineering plastics, and various industrial resins. The company maintains a focus on operational efficiency and product quality to serve its diverse client base within the chemical manufacturing landscape.

Recent filings

Filing Released Lang Actions
Newspaper Advertisement of the Audited Financial Result for Quarter ended 31 March 2026
Report Publication Announcement Classification · 87% confidence The document is a brief letter to the stock exchange notifying BSE Limited that the company has published its “Audited Financial Result for the quarter and financial year ended on March 31, 2026” as a newspaper advertisement. It does not contain the actual financial data but merely announces the publication of the results in newspapers. Under the “menu vs meal” rule, this is an announcement of report publication rather than the report itself. Therefore, it should be classified as a Report Publication Announcement (RPA).
2026-06-01 English
Outcome of the Board Meeting held on Saturday, 30 May, 2026
Interim / Quarterly Report Classification · 85% confidence The document is a SEBI Listing Regulations (Regulations 30 & 33) filing announcing and enclosing the audited financial results for the quarter and full year ended 31 March 2026. It includes the full standalone financial statements (P&L, Assets & Liabilities, Cash Flows) and the Independent Auditor’s Report, not merely a summary. This corresponds to a comprehensive quarterly (and year-end) financial report rather than a brief earnings release or a full annual report. Therefore, it is classified as an Interim / Quarterly Report. FY 2026
2026-05-30 English
Caprolactam Chemicals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2026 ,inter alia, to consider and approve Prior Intimation of Board ....
Regulatory Filings Classification · 79% confidence The document is a notice under SEBI Listing Regulations informing the exchange and shareholders of an upcoming Board meeting date to consider and approve audited financial results. It does not contain any financial data, results, or the report itself, nor is it the report’s publication; rather it is a regulatory announcement. This fits the general “Regulatory Filings” category (RNS).
2026-05-06 English
Non Applicability of Regulation 23(9) of SEBI (LODR) Regulations, 2015
Regulatory Filings Classification · 88% confidence The document is a formal letter to the BSE Limited under Listing Obligations (SEBI LODR), specifically stating non-applicability of a regulatory disclosure requirement (Regulation 23(9) related to Related Party Transactions). It contains no financial statements or report attachments but is an exchange filing announcing compliance status under SEBI regulations. This fits the “Regulatory Filings (RNS)” category (general regulatory announcements) rather than a standalone financial report or other specific filing category.
2026-04-22 English
Format of Initial Disclosure to be made by an entity identified as a Large Corporate. Sr. No. Particulars Details ....
Regulatory Filings Classification · 72% confidence The document is a brief compliance letter addressed to BSE, referencing SEBI/BSE circulars on fund raising by issuance of debt securities by large entities and stating the company does not qualify as a large entity. It contains no substantive financial data or actual financing/investment details, nor is it a report of results or a regulatory form filing of audit or annual report data. This is a general regulatory announcement to an exchange under listing rules, fitting the fallback category for miscellaneous compliance filings.
2026-04-18 English
Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018
Regulatory Filings Classification · 90% confidence The document is a confirmation certificate under SEBI (Depositories and Participants) Regulations, 2018, attesting to the dematerialisation process for the quarter ended March 31, 2026. It is a compliance certificate/attestation filed with the stock exchange and does not contain financial statements or substantive analysis. Under the Certification Rule, such officer certifications and regulatory compliance filings are classified as Regulatory Filings (RNS), not as an interim report or other substantive report.
2026-04-04 English

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.